vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Clearwater Analytics Holdings, Inc. (CWAN). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $217.5M, roughly 1.7× Clearwater Analytics Holdings, Inc.). AdvanSix Inc. runs the higher net margin — -0.8% vs -5.4%, a 4.6% gap on every dollar of revenue. On growth, Clearwater Analytics Holdings, Inc. posted the faster year-over-year revenue change (72.0% vs 9.4%). Clearwater Analytics Holdings, Inc. produced more free cash flow last quarter ($52.3M vs $36.1M). Over the past eight quarters, Clearwater Analytics Holdings, Inc.'s revenue compounded faster (45.5% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Clearwater Analytics Holdings, Inc. is an American software-as-a-service (SaaS) fintech company that provides automated investment accounting, performance, compliance, and risk reporting worldwide. Clearwater is a publicly traded company headquartered in Boise, Idaho, with additional offices in London, Edinburgh, New York City and Noida.
ASIX vs CWAN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $217.5M |
| Net Profit | $-2.8M | $-11.8M |
| Gross Margin | 7.6% | 67.2% |
| Operating Margin | -0.7% | -3.1% |
| Net Margin | -0.8% | -5.4% |
| Revenue YoY | 9.4% | 72.0% |
| Net Profit YoY | -892.9% | -102.8% |
| EPS (diluted) | $-0.11 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $217.5M | ||
| Q3 25 | $374.5M | $205.1M | ||
| Q2 25 | $410.0M | $181.9M | ||
| Q1 25 | $377.8M | $126.9M | ||
| Q4 24 | $329.1M | $126.5M | ||
| Q3 24 | $398.2M | $115.8M | ||
| Q2 24 | $453.5M | $106.8M | ||
| Q1 24 | $336.8M | $102.7M |
| Q4 25 | $-2.8M | $-11.8M | ||
| Q3 25 | $-2.6M | $-10.3M | ||
| Q2 25 | $31.4M | $-23.2M | ||
| Q1 25 | $23.3M | $6.5M | ||
| Q4 24 | $352.0K | $419.3M | ||
| Q3 24 | $22.3M | $3.6M | ||
| Q2 24 | $38.9M | $-430.0K | ||
| Q1 24 | $-17.4M | $1.9M |
| Q4 25 | 7.6% | 67.2% | ||
| Q3 25 | 6.8% | 65.6% | ||
| Q2 25 | 14.3% | 65.1% | ||
| Q1 25 | 14.2% | 73.3% | ||
| Q4 24 | 3.4% | 73.5% | ||
| Q3 24 | 14.4% | 72.9% | ||
| Q2 24 | 17.9% | 72.0% | ||
| Q1 24 | 0.9% | 72.6% |
| Q4 25 | -0.7% | -3.1% | ||
| Q3 25 | -0.9% | 3.2% | ||
| Q2 25 | 7.7% | -8.0% | ||
| Q1 25 | 7.7% | 5.6% | ||
| Q4 24 | -3.9% | 1.0% | ||
| Q3 24 | 7.5% | 6.3% | ||
| Q2 24 | 11.5% | 3.6% | ||
| Q1 24 | -7.0% | -0.2% |
| Q4 25 | -0.8% | -5.4% | ||
| Q3 25 | -0.7% | -5.0% | ||
| Q2 25 | 7.7% | -12.8% | ||
| Q1 25 | 6.2% | 5.1% | ||
| Q4 24 | 0.1% | 331.5% | ||
| Q3 24 | 5.6% | 3.1% | ||
| Q2 24 | 8.6% | -0.4% | ||
| Q1 24 | -5.2% | 1.8% |
| Q4 25 | $-0.11 | $-0.04 | ||
| Q3 25 | $-0.10 | $-0.04 | ||
| Q2 25 | $1.15 | $-0.09 | ||
| Q1 25 | $0.86 | $0.03 | ||
| Q4 24 | $0.02 | $1.65 | ||
| Q3 24 | $0.82 | $0.02 | ||
| Q2 24 | $1.43 | $0.00 | ||
| Q1 24 | $-0.65 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $91.2M |
| Total DebtLower is stronger | — | $822.6M |
| Stockholders' EquityBook value | $815.2M | $2.0B |
| Total Assets | $1.7B | $3.0B |
| Debt / EquityLower = less leverage | — | 0.41× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $91.2M | ||
| Q3 25 | $23.7M | $64.1M | ||
| Q2 25 | $18.4M | $71.9M | ||
| Q1 25 | $8.3M | $282.9M | ||
| Q4 24 | $19.6M | $255.5M | ||
| Q3 24 | $17.3M | $305.8M | ||
| Q2 24 | $12.1M | $257.9M | ||
| Q1 24 | $20.6M | $267.6M |
| Q4 25 | — | $822.6M | ||
| Q3 25 | — | $838.9M | ||
| Q2 25 | — | $878.1M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $43.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $815.2M | $2.0B | ||
| Q3 25 | $818.2M | $2.0B | ||
| Q2 25 | $823.7M | $2.0B | ||
| Q1 25 | $794.4M | $1.1B | ||
| Q4 24 | $774.6M | $1.0B | ||
| Q3 24 | $766.4M | $403.2M | ||
| Q2 24 | $746.6M | $380.6M | ||
| Q1 24 | $713.2M | $406.2M |
| Q4 25 | $1.7B | $3.0B | ||
| Q3 25 | $1.7B | $3.0B | ||
| Q2 25 | $1.6B | $3.0B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.6B | $1.2B | ||
| Q3 24 | $1.5B | $623.5M | ||
| Q2 24 | $1.5B | $585.1M | ||
| Q1 24 | $1.5B | $547.8M |
| Q4 25 | — | 0.41× | ||
| Q3 25 | — | 0.42× | ||
| Q2 25 | — | 0.45× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $55.3M |
| Free Cash FlowOCF − Capex | $36.1M | $52.3M |
| FCF MarginFCF / Revenue | 10.0% | 24.0% |
| Capex IntensityCapex / Revenue | 7.7% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $164.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $55.3M | ||
| Q3 25 | $26.6M | $49.0M | ||
| Q2 25 | $21.1M | $47.1M | ||
| Q1 25 | $11.4M | $24.5M | ||
| Q4 24 | $64.2M | $-29.2M | ||
| Q3 24 | $57.3M | $49.6M | ||
| Q2 24 | $50.2M | $43.9M | ||
| Q1 24 | $-36.2M | $10.0M |
| Q4 25 | $36.1M | $52.3M | ||
| Q3 25 | $66.0K | $44.9M | ||
| Q2 25 | $-7.2M | $44.1M | ||
| Q1 25 | $-22.6M | $23.0M | ||
| Q4 24 | $29.8M | $-30.0M | ||
| Q3 24 | $26.8M | $48.1M | ||
| Q2 24 | $16.7M | $42.4M | ||
| Q1 24 | $-71.6M | $8.6M |
| Q4 25 | 10.0% | 24.0% | ||
| Q3 25 | 0.0% | 21.9% | ||
| Q2 25 | -1.7% | 24.2% | ||
| Q1 25 | -6.0% | 18.2% | ||
| Q4 24 | 9.1% | -23.7% | ||
| Q3 24 | 6.7% | 41.5% | ||
| Q2 24 | 3.7% | 39.7% | ||
| Q1 24 | -21.3% | 8.4% |
| Q4 25 | 7.7% | 1.4% | ||
| Q3 25 | 7.1% | 2.0% | ||
| Q2 25 | 6.9% | 1.6% | ||
| Q1 25 | 9.0% | 1.2% | ||
| Q4 24 | 10.4% | 0.6% | ||
| Q3 24 | 7.7% | 1.3% | ||
| Q2 24 | 7.4% | 1.4% | ||
| Q1 24 | 10.5% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.49× | 3.76× | ||
| Q4 24 | 182.29× | -0.07× | ||
| Q3 24 | 2.57× | 13.66× | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | 5.29× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
CWAN
Segment breakdown not available.
